Product
Oliceridine
Name
OLINVYK
INN Name
OLICERIDINE
FDA Approved
Yes
5 clinical trials
1 organization
10 indications
1 document
Indication
Postoperative Nausea and VomitingIndication
PainIndication
BurnsIndication
Adverse Drug EventIndication
Respiratory DepressionIndication
NauseaIndication
PostoperativeIndication
Major SurgeryIndication
Postoperative AnalgesiaIndication
AnalgesicClinical trial
Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting in Laparoscopic Colorectal Surgery: A Randomized TrialStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
A pRospective, Case-controlled Evaluation of oLIceridine for Moderate or sEVEre Pain in Patients With Acute Burn Injuries. (RELIEVE)Status: Completed, Estimated PCD: 2023-09-30
Clinical trial
Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Enhanced Postoperative Analgesia and Accelerated Recovery With Oliceridine: A Study on G-Protein Biased μ-Opioid AgonistStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative PainStatus: Not yet recruiting, Estimated PCD: 2024-12-25
Document
DailyMed Label: OLINVYKOrganization
Trevena, Inc.